Most people are told they “have” or “don’t have” a thyroid problem — as if it’s a light switch. The reality is closer to a slow sunset. Hashimoto’s is a progressive condition that moves through stages, often over many years (American Thyroid Association).
Stage 1 — Genetic predisposition
Hashimoto’s tends to run in families. At this stage there are no antibodies, no symptoms, and nothing on a lab test.
Stage 2 — A trigger flips the switch
In genetically susceptible people, triggers — intense stress, infections, pregnancy, perimenopause — can activate the immune system against the thyroid. Nothing shows on a standard thyroid panel yet (StatPearls).
Stage 3 — Silent autoimmunity (antibodies up, labs “normal”)
Your immune system is now producing antibodies (TPO and/or thyroglobulin) that attack your thyroid tissue. But your thyroid compensates, and TSH, T4, and T3 can all still look “normal.” The antibodies can be present for years before your standard labs ever move (ATA).
Stage 4 — Subclinical hypothyroidism
Your TSH starts to rise while T4 may still scrape into the “normal” range. This is exactly the population in which myo-inositol plus selenium has been studied and shown to lower TSH and improve well-being (Nordio & Basciani, 2017).
Stage 5 — Overt hypothyroidism
TSH is high, free T4 is low, and now you get the prescription (IntechOpen). Levothyroxine replaces the missing hormone, your labs normalize… and yet the autoimmune attack that’s been running since Stage 2 continues untouched.
Clinically-dosed selenium has repeated evidence for lowering the antibodies that define the attack (Gärtner et al., 2002). That’s a lever on the process, not just the end-stage hormone shortage.